Literature DB >> 10628884

Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response.

D N Klein1, A F Schatzberg, J P McCullough, F Dowling, D Goodman, R H Howland, J C Markowitz, C Smith, M E Thase, A J Rush, L LaVange, W M Harrison, M B Keller.   

Abstract

BACKGROUND: The clinical and etiological significance of the early-late onset distinction in chronic major depressive disorder was explored.
METHOD: Subjects were 289 outpatients with DSM-III-R chronic major depression drawn from a multi-site study comparing the efficacy of sertraline and imipramine in the acute and long-term treatment of chronic depression. Patients received comprehensive evaluations using semi-structured interviews and rating scales.
RESULTS: Early-onset chronic major depression was associated with a longer index major depressive episode and higher rates of recurrent major depressive episodes, comorbid personality disorders, lifetime substance use disorders, depressive personality traits, and a history of psychiatric hospitalization. In addition, more early-onset patients tended to have a family history of mood disorders. The early-late onset distinction was not associated with differences in symptom severity, functional impairment, or treatment response. LIMITATIONS: Family members were not interviewed directly; there were a large number of statistical comparisons; and interrater reliability of the assessments was not evaluated.
CONCLUSIONS: Early-onset chronic major depression has a more malignant course and is associated with greater comorbidity than late-onset chronic major depression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10628884     DOI: 10.1016/s0165-0327(99)00020-8

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  55 in total

Review 1.  Risk for recurrence in depression.

Authors:  Stephanie L Burcusa; William G Iacono
Journal:  Clin Psychol Rev       Date:  2007-03-03

2.  Age of onset and family history as indicators of polygenic risk for major depression.

Authors:  Anna R Docherty; Alexis C Edwards; Fuzhong Yang; Roseann E Peterson; Chelsea Sawyers; Daniel E Adkins; Ashlee A Moore; Bradley T Webb; Silviu A Bacanu; Jonathan Flint; Kenneth S Kendler
Journal:  Depress Anxiety       Date:  2017-02-02       Impact factor: 6.505

3.  Predictive value of family history on severity of illness: the case for depression, anxiety, alcohol dependence, and drug dependence.

Authors:  Barry J Milne; Avshalom Caspi; HonaLee Harrington; Richie Poulton; Michael Rutter; Terrie E Moffitt
Journal:  Arch Gen Psychiatry       Date:  2009-07

4.  Prevention of Depression in At-Risk Adolescents: Predictors and Moderators of Acute Effects.

Authors:  V Robin Weersing; Wael Shamseddeen; Judy Garber; Steven D Hollon; Gregory N Clarke; William R Beardslee; Tracy R Gladstone; Frances L Lynch; Giovanna Porta; Satish Iyengar; David A Brent
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2016-01-18       Impact factor: 8.829

5.  Resting frontal EEG asymmetry as an endophenotype for depression risk: sex-specific patterns of frontal brain asymmetry.

Authors:  Jennifer L Stewart; Andrew W Bismark; David N Towers; James A Coan; John J B Allen
Journal:  J Abnorm Psychol       Date:  2010-08

6.  Brain-derived neurotrophic factor (BDNF) Val66Met and adulthood chronic stress interact to affect depressive symptoms.

Authors:  Rong Jiang; Beverly H Brummett; Michael A Babyak; Ilene C Siegler; Redford B Williams
Journal:  J Psychiatr Res       Date:  2012-11-08       Impact factor: 4.791

7.  Age-specific familial risks of depression: a nation-wide epidemiological study from Sweden.

Authors:  Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  J Psychiatr Res       Date:  2007-11-05       Impact factor: 4.791

Review 8.  Psychosocial and clinical predictors of response to pharmacotherapy for depression.

Authors:  R Michael Bagby; Andrew G Ryder; Carolina Cristi
Journal:  J Psychiatry Neurosci       Date:  2002-07       Impact factor: 6.186

Review 9.  Chronic depression: update on classification and treatment.

Authors:  Dana C Torpey; Daniel N Klein
Journal:  Curr Psychiatry Rep       Date:  2008-12       Impact factor: 5.285

10.  Replication of scopolamine's antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial.

Authors:  Wayne C Drevets; Maura L Furey
Journal:  Biol Psychiatry       Date:  2010-01-15       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.